{"id":"W3168836567","doi":"10.1200/jco.2021.39.15_suppl.7519","title":"Glofitamab step-up dosing (SUD): Complete response rates in updated efficacy data in heavily pretreated relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL) patients (pts).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Dosing; Refractory (planetary science); Internal medicine; Cytokine release syndrome; Gastroenterology; Rituximab; Neutropenia; Lymphoma; Surgery; Chemotherapy; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015376,0.0002444012,0.0004585723,0.0003531976,0.0001230938,0.0005332225,0.000336703,0.00027053,0.001195312],"category_scores_gemma":[0.001307092,0.0001547935,0.0005280775,0.0004261433,0.0001381087,0.0003429155,0.0002622926,0.0006199689,0.0002739258],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004899052,"about_ca_system_score_gemma":0.0002488163,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007291746,"about_ca_topic_score_gemma":0.001661516,"domain_scores_codex":[0.9996152,0.0001288775,0.00004933685,0.00008012141,0.00008445682,0.00004197231],"domain_scores_gemma":[0.9988147,0.0003054918,0.000535703,0.0001160906,0.00008677867,0.0001412022],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.08265205,0.001822125,0.4986355,0.000861847,0.002527048,0.0002769614,0.0003446288,0.004247207,0.04078452,0.0001961207,0.008418125,0.3592338],"study_design_scores_gemma":[0.004547117,0.02949645,0.9404176,0.00008314071,0.001599092,0.00128529,0.00007119864,0.00181399,0.008846629,0.00009664056,0.01170745,0.00003532402],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881315,0.004352105,0.0006055486,0.0001289021,0.00001654116,0.0002413134,0.004269755,0.00008422694,0.00217011],"genre_scores_gemma":[0.9924116,0.000748684,0.0004503482,0.0001569168,0.00002018534,0.00009705118,0.005750581,0.00001225269,0.0003522879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0015376,"threshold_uncertainty_score":0.008131742,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1588295856077462,"score_gpt":0.4813478106215453,"score_spread":0.3225182250137991,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}